For research use only. Not for therapeutic Use.
BTB-1(CAT: I005100) is a novel small-molecule inhibitor of Kif18A, a mitotic motor protein essential for proper chromosome alignment during cell division. Identified through a high-throughput screen by Catarinella et al., it inhibits Kif18A’s microtubule (MT)-stimulated ATPase activity with an IC₅₀ of 1.7–1.9 µM. BTB-1 is highly selective within the kinesin subgroup, showing minimal effects on related proteins like Kif4, Eg5, and CENP-E. It acts as an ATP-competitive and MT-uncompetitive inhibitor, specifically targeting ATPase activity of the MT-bound Kif18A and reversibly blocking its MT gliding ability. This compound is particularly valuable in cell cycle and cancer research, serving as a tool for elucidating Kif18A’s roles in mitosis and exploring its therapeutic potential in targeting mitotic dysfunctions.
Catalog Number | I005100 |
CAS Number | 86030-08-2 |
Synonyms | BTB1; BTB 1 ; BTB-1.;4-chloro-2-nitro-1-(phenylsulfonyl)benzene |
Molecular Formula | C12H8ClNO4S |
Purity | ≥95% |
Target | Cytoskeleton |
Solubility | Soluble in DMSO, not in water |
Storage | 0 - 4 °C for short term or -20 °C for long term |
IUPAC Name | 1-(benzenesulfonyl)-4-chloro-2-nitrobenzene |
InChI | InChI=1S/C12H8ClNO4S/c13-9-6-7-12(11(8-9)14(15)16)19(17,18)10-4-2-1-3-5-10/h1-8H |
InChIKey | VZDUQPHKUBZMLW-UHFFFAOYSA-N |
SMILES | C1=CC=C(C=C1)S(=O)(=O)C2=C(C=C(C=C2)Cl)[N+](=O)[O-] |